Aurora Cannabis Stock News

International Assets Investment Management LLC increased its stake in shares of Aurora Cannabis Inc. (NYSE:ACB) by 104.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 25,887 shares of the companys stock after acquiring an additional 13,254 shares during the quarter. International Assets Investment Management []

22nd Century Group, Aurora Cannabis And Cronos Group Set Sights On Cannabinoid Biosynthesis

During the recent session, Aurora Cannabis Inc. (NASDAQ:ACB)’s traded shares were 1.06 million, with the beta value of the company hitting 3.09. At the last check today, the stock’s price was $5.66, reflecting an intraday loss of -1.05% or -$0.06. The 52-week high for the ACB share is $18.98, that puts it down -235.34 from … Aurora Cannabis Inc. (NASDAQ: ACB) Rose 4.24% From Its 52-Week Low, But YTD Numbers Fell -31.17%. Here’s What You Need To Know At This Time Read More »

Aurora Cannabis Inc. and HEXO Corp. are Canadian cannabis companies that benefited from the legalization status in 2018. However, both have not achieved EBITDA profitability amongst the intense compet

Aurora Cannabis Inc. (NYSE:ACB) shares reached a new 52-week low on Wednesday . The company traded as low as $5.53 and last traded at $5.53, with a volume of 144342 shares traded. The stock had previously closed at $5.87. A number of research firms recently weighed in on ACB. Jefferies Financial Group restated a hold []

Wall Street warns of an impending crisis at Hexo.

Canadian marijuana titan Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) together with 22nd Century Group, Inc. (NASDAQ:XXII) will license biosynthesis intellectual property to Cronos Group Inc. (NASDAQ:C

Aurora Cannabis Inc. (the “Company” or “Aurora“) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to acknowledge the Company’s increased ranking in The Globe and Mail’s 2021 annual Report on Business review of Corporate Boards, known as Board Games. As recognized in the 2021 Board Games results, Aurora received 77 […] The post Aurora Cannabis Again Scores Highest Among Cannabis Corporate Boards in The Globe and Mail’s Board Games Report appeared first on Technical420 .

Canadian cannabis giant Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced Monday that its ranking has considerably increased in the recent Globe and Mail's 2021 annual Report on Business Review

Equities research analysts forecast that Aurora Cannabis Inc. (NYSE:ACB) will announce $47.12 million in sales for the current quarter, according to Zacks. Four analysts have issued estimates for Aurora Cannabis earnings. The lowest sales estimate is $44.05 million and the highest is $51.35 million. Aurora Cannabis reported sales of $51.93 million in the same quarter [] The post Aurora Cannabis Inc. (NYSE:ACB) Expected to Announce Quarterly Sales of $47.12 Million appeared first on ETF Daily News .

Charlies (OTCMKTS:CHUC) and Aurora Cannabis (NYSE:ACB) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Analyst Ratings This is a breakdown of current ratings and price targets for Charlies and [] The post Head to Head Contrast: Aurora Cannabis (NYSE:ACB) versus Charlies (OTCMKTS:CHUC) appeared first on ETF Daily News .

Aurora Cannabis Inc. (TSE:ACB) has been assigned a consensus rating of Hold from the ten ratings firms that are presently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation and five have given a hold recommendation to the company. The average 12-month price objective among brokers that have []

Wells Fargo just shouted "sell!" -- but investors bought cannabis stocks instead.

Energy stocks helped Canada''s main stock index rise on Monday, as oil prices jumped after concerns around the Omicron coronavirus variant eased, although weakness in pot producers limited gains. At 9:46 a.m. ET, the Toronto Stock Exchange''s S&P/TSX composite index was up 53.94 points, or 0.26%, at 20,687.21. The energy sector jumped 1.3% as oil climbed by $2 a barrel on hopes the Omicron coronavirus variant would have a less damaging economic impact if its symptoms proved mostly mild. "Markets are probably going to be volatile until we get through the Federal Reserve meeting, which is next week and so there''s going to be people that are going to be holding off till you see if the Fed changes his tone at all," said Gregory Taylor, portfolio manager at Purpose Investments. The US Federal Reserve is set to meet next week, and investors expect the central bank to start aggressively tightening its stimulus. Toronto index turns negative as pot producers weigh Limiting advances was the healthcare sector down 2.8%, with all major pot producers including OrganiGram Holdings Inc, Tilray Inc, Canopy Growth Corp, Aurora Cannabis Inc falling more than 4%.